Vet Pathol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brunetti, B.
Right arrow Articles by Benazzi, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brunetti, B.
Right arrow Articles by Benazzi, C.
Vet Pathol 42:781-787 (2005)
© 2005 American College of Veterinary Pathologists

E-Cadherin and ß-catenin Reduction Influence Invasion but not Proliferation and Survival in Canine Malignant Mammary Tumors

B. Brunetti, G. Sarli, R. Preziosi, I. Monari and C. Benazzi

Department of Veterinary Public Health and Animal Pathology, Division of Veterinary Pathology, Ozzano Emilia, Bologna, Italy

E-Cadherin and ß-catenin are known for their role in tumor invasion, but both proteins also exert an influence on tumor proliferation. This study, performed on canine mammary tumors, aimed to analyze the influence of E-cadherin (E-cad) and ß-catenin (ß-cat), immunohistochemically assessed singly and in combination (E-cad/ß-cat), on survival and their relationship with several proliferation indices (AgNOR index, MIB1 index, mitotic index). Immunohistochemistry was carried out on 60 formalin-fixed, paraffin wax-embedded specimens of canine mammary malignancies. The labeling was defined as preserved when prevalent on cell membranes of more than 75% of cells and reduced in other forms of expression (i.e., membranous less than 75%, cytoplasmic, and negative). E-cad, ß-cat, and E-cad/ß-cat were preserved respectively in 22, 12, and 11 out of 60 cases. Immunohistochemical expression of the two proteins in the same tumors was significantly correlated (P = 0.0001; R = 0.57). Survival analysis revealed no difference in outcome comparing the preserved versus reduced cases (E-cad, P = 0.31; ß-cat, P = 0.29; E-cad/ß-cat P = 0.36). Grouping cases for histologic invasiveness, the expression of E-cad or ß-cat and E-cad/ß-cat showed a progressive reduction that paralleled an increase in invasiveness from noninfiltrating to stage-II tumors (E-cad, P < 0.001; ß-cat, P < 0.05; E-cad/ß-cat, P < 0.05). No significant difference was obtained comparing mitotic index, MIB 1 index, and AgNOR index by analysis of variance between the cases grouped for preserved or reduced E-cad, ß-cat, and E-cad/ß-cat variables. In conclusion, reduced expression of E-cad, ß-cat, or E-cad/ß-cat was significantly associated with the progression from noninfiltrating to highly infiltrating tumors but not with proliferation or survival.


Key words: AgNOR; beta-catenin; dogs; E-cadherin; mammary tumors; MIB1; mitotic index.

Request reprints from B. Brunetti, Department of Veterinary Public Health and Animal Pathology, Division of Veterinary Pathology, via Tolara di Sopra 50-40064, Ozzano Emilia, Bologna (Italy). E-mail: bbrunetti{at}vet.unibo.it







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Veterinary Pathologists.